Document is current
Any future updates will be listed below
-
Authors
Katsanis, Nicholas
Mourtzi, Niki
Quinto-Cortés, Consuelo D.
Martagon, Alexandro J.
Ioannidis, Alexander G.
De La Vega, Francisco M.
Gulcher, Jeff
Lee, Ming Ta Michael
Faghihi, Mohammad A.
Lopez-Pineda, Arturo
Moreno-Grau, Sonia
Montserrat, Daniel Mas
Barrabés, Míriam
Bonet, David
Fernandez, Pavel Salazar
Wall, Jeff
Moatamed, Babak
Mehta, Roopa
Galan-Ramirez, Gabriela A.
Zubirán, Rafael
Elias-Lopez, Daniel
Tusié-Luna, Teresa
Aguilar-Salinas, Carlos A.
Bustamante, Carlos D.
,
-
Funding
Funding for this research was provided by:
Internal Galatea Funding
Mexican FH Registry
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 17 September 2025
First Online: 24 November 2025
Declarations
:
: This research protocol has been approved by the Institutional Research and Ethics Committees (Institutional Review Board, IRB) of the National Institute of Health Sciences and Nutrition "Salvador Zubirán", in Mexico City, under reference number 2571. The sample identifiers used in this study are known only to the research team and do not correspond to any identifiers recognized by individuals outside the study, including hospital staff or participants themselves.
: CDQC, NM, ALP, SMG, DM, MB, DB, PSF, JW, BM, JG, MTML, MAF, AGI, FMDLV, CDB, and NK are or were employees or contractors from Galatea Bio, Inc. Theremaining authors declare no conflict of interest regarding the publication of this article.
: Individual-level data used in this research were collected in a healthcare setting and are subject to controlled access for privacy reasons. The ethics committee and/or informed consent does not allow for public availability. This research has been conducted using the UK Biobank Resource under Application Number 89006.
